These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2388322

  • 1. Usefulness and limitations of methotrexate, vinblastine, doxorubicin and cisplatin for the treatment of advanced urothelial cancer.
    Igawa M, Ohkuchi T, Ueki T, Ueda M, Okada K, Usui T.
    J Urol; 1990 Sep; 144(3):662-5. PubMed ID: 2388322
    [Abstract] [Full Text] [Related]

  • 2. [Methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer--analysis of efficacy and toxicity].
    Igawa M, Kadena H, Ohkuchi T, Ueda M, Usui T.
    Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1627-36. PubMed ID: 1770701
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
    Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N.
    Cancer; 1989 Dec 15; 64(12):2448-58. PubMed ID: 2819654
    [Abstract] [Full Text] [Related]

  • 4. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.
    Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC.
    J Urol; 1985 Mar 15; 133(3):403-7. PubMed ID: 4038749
    [Abstract] [Full Text] [Related]

  • 5. M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.
    Igawa M, Kadena H, Ueda M, Usui T.
    Cancer Chemother Pharmacol; 1994 Mar 15; 35 Suppl():S1-4. PubMed ID: 7527732
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.
    Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, Weiselberg LR.
    J Urol; 1988 Mar 15; 139(3):461-9. PubMed ID: 3343727
    [Abstract] [Full Text] [Related]

  • 8. Cisplatin-based chemotherapy for the treatment of advanced transitional-cell carcinoma of the urinary tract--a preliminary report.
    Lee MH, Chen MT, Chen KK, Lin AT, Lee YH, Lee LM, Chang YM, Chang LS, Liu JM, Hsieh RK.
    Cancer Chemother Pharmacol; 1992 Mar 15; 30 Suppl():S81-4. PubMed ID: 1394825
    [Abstract] [Full Text] [Related]

  • 9. [Combination chemotherapy of advanced urothelial cancer with methotrexate, vinblastine, adriamycin and cisplatin (M-VAC)].
    Nakagawa S, Nakao M, Toyoda K, Nukui M, Takada H, Ebisui K, Watanabe H, Kobayashi T, Maegawa M.
    Nihon Hinyokika Gakkai Zasshi; 1988 Sep 15; 79(9):1510-5. PubMed ID: 3244217
    [No Abstract] [Full Text] [Related]

  • 10. Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma.
    Dodd PM, McCaffrey JA, Mazumdar M, Scher H, Vlamis V, Higgins G, Herr H, Bajorin DF.
    Cancer; 1999 Mar 01; 85(5):1145-50. PubMed ID: 10091800
    [Abstract] [Full Text] [Related]

  • 11. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
    Scher HI.
    J Urol; 1992 Nov 01; 148(5):1625-6. PubMed ID: 1433578
    [No Abstract] [Full Text] [Related]

  • 12. The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy.
    Hsieh MC, Chiang PH, Rau KM, Chen YY, Su YL, Huang CH.
    Urol Oncol; 2015 Nov 01; 33(11):495.e9-495.e14. PubMed ID: 26254698
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate, vinblastine, adriamycin and cisplatin versus methotrexate and cisplatin in advanced urothelial cancer. A randomized study.
    Pizzocaro G, Milani A, Piva L, Faustini M, Spino E.
    Eur Urol; 1991 Nov 01; 20(2):89-92. PubMed ID: 1752280
    [Abstract] [Full Text] [Related]

  • 14. [Experience with combination chemotherapy consisting of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer].
    Nishio Y, Shirahase T, Shichiri Y, Habuchi T, Matsuda T, Nishimura K, Hida S, Okada Y, Yoshida O.
    Hinyokika Kiyo; 1988 Aug 01; 34(8):1371-5. PubMed ID: 3195405
    [Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of M-VAC chemotherapy (methotrexate, vinblastine, adriamycin and cisplatin) for advanced urothelial cancer].
    Gohji K, Takenaka A, Goto A, Hara I, Matsumoto O, Kamidono S, Hamami G, Itani A, Harada K, Tadera N.
    Nihon Hinyokika Gakkai Zasshi; 1989 Mar 01; 80(3):321-8. PubMed ID: 2659869
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of dose-intensified MEC (methotrexate, epirubicin and cisplatin) chemotherapy for advanced urothelial carcinoma: a prospective randomized trial comparing MEC and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). Japanese Urothelial Cancer Research Group.
    Kuroda M, Kotake T, Akaza H, Hinotsu S, Kakizoe T.
    Jpn J Clin Oncol; 1998 Aug 01; 28(8):497-501. PubMed ID: 9769784
    [Abstract] [Full Text] [Related]

  • 17. Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin chemotherapy for advanced urothelial cancers.
    Ogawa T, Gotoh A, Takenaka A, Hara I, Gohji K, Arakawa S, Matsumoto O, Kamidono S.
    Cancer Chemother Pharmacol; 1992 Aug 01; 30 Suppl():S66-71. PubMed ID: 1394822
    [Abstract] [Full Text] [Related]

  • 18. Factors affecting the outcome of patients with advanced urothelial cancer following chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin.
    Igawa M, Ohkuchi T, Ueda M, Usui T.
    Cancer Chemother Pharmacol; 1992 Aug 01; 30 Suppl():S77-80. PubMed ID: 1394824
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) for advanced TCC of urothelium.
    Huang CH, Hsieh HH, Wang JM, Hsu K, Yang WC, Yu TJ.
    J Formos Med Assoc; 1992 Jul 01; 91(7):699-703. PubMed ID: 1360298
    [Abstract] [Full Text] [Related]

  • 20. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
    McCaffrey JA, Hilton S, Mazumdar M, Sadan S, Heineman M, Hirsch J, Kelly WK, Scher HI, Bajorin DF.
    J Clin Oncol; 1997 Jun 01; 15(6):2449-55. PubMed ID: 9196161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.